Position in HRMY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$3,262,336
+$1,584,537 QoQ
Shares Held
89,600
+49.6% QoQ
Ownership
0.154%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#82
of 328 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 25%
Shared 0%
None 75%
Common Shares in HRMY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DENALI ADVISORS LLC holds $3,885,876 across 2 Biotechnology names. HRMY ranks #1 (84.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HRMY |
Harmony Biosciences Holdings, Inc.
This page
|
89,600 | $3,262,336 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,000 | $623,540 |
All Filings in HRMY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,262,336 | 89,600 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,677,799 | 59,900 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $3,660,723 | 97,828 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $2,811,891 | 102,028 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $2,507,997 | 79,367 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $2,634,190 | 79,367 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $3,589,444 | 104,314 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $2,060,000 | 51,500 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $425,397 | 14,100 | Shares | Sole | 2024-08-09 | |
| No filing history on record for this holder in this stock. | ||||||